LA
Laxmi Dental Ltd (LAXMIDENTL)
₹187.57
Mkt cap
₹1,032 Cr
P/E ratio
28.40
P/B
3.90
Div yield
0.00%
ROE
14.80%
ROCE
15.00%
EPS (TTM)
₹6.60
Book value
₹48
52W range
156–315
Sector
Healthcare
Price history
Previous close
Incorporated in 2004, Laxmi Dental is an integrated dental products company offering a comprehensive portfolio of Dental Products [1]
NSE LAXMIDENTLBSE 544339
Health check
Mixed
ValuationCheap
ProfitabilityAverage
GrowthModerate
TechnicalsBearish
52-week range
−40.44% from high₹188
₹156+20.33% from low₹315
Current
₹187.57
Prev close
₹192.56
Day
−2.59%
Price performance
1D
−2.37%
1W
−7.84%
1M
+6.40%
3M
−5.14%
6M
−9.50%
1Y
−39.56%
YTD
−30.75%
Financials
Revenue, profit & margin
P/E ratio
28.4×
LAXMIDENTL is 23% below the sector median of 36.9×
LAXMIDENTL28.4×
Sector median36.9×
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 48 | 55 | 60 | 57 | 62 | 61 | 66 | 72 | 66 | 74 | 75 | 80 | |
| YoY Sales growth | +29% | +10% | +10% | +27% | +7% | +22% | +14% | +10% | |||||
| Expenses | 44 | 43 | 46 | 48 | 52 | 51 | 54 | 61 | 59 | 60 | 60 | 64 | |
| Operating Profit | 4 | 12 | 14 | 9 | 10 | 10 | 12 | 11 | 7 | 14 | 14 | 15 | |
| OPM % | 8% | 21% | 23% | 15% | 16% | 16% | 18% | 15% | 11% | 18% | 19% | 19% | |
| Other Income | -0 | -0 | 6 | 1 | 1 | 2 | 2 | 2 | -4 | 2 | 2 | 2 | |
| Interest | 1 | 1 | 1 | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Depreciation | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | |
| Profit before tax | -1 | 7 | 16 | 5 | 5 | 6 | 10 | 9 | -1 | 11 | 12 | 12 | |
| Tax % | -140% | 16% | 11% | 23% | 23% | 41% | 24% | 20% | -175% | 4% | 21% | 19% | |
| Net Profit | 2 | 8 | 17 | 6 | 5 | 4 | 8 | 9 | 2 | 10 | 10 | 10 | |
| EPS in Rs | 0.44 | 1.45 | 3.25 | 1.14 | 0.93 | 0.78 | 1.53 | 1.55 | 0.36 | 1.83 | 1.87 | 1.82 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move +0.49% · closed higher next day 4 of last 8
| Q3FY25 | Q4FY25 | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 | Q2FY27 | |
|---|---|---|---|---|---|---|---|---|
| Broadcast | 14 Feb '25◦ | 28 May '25◦ | 12 Aug '25◦ | 18 Dec '25◦ | 10 Feb '26◦ | 21 May '26◦ | 11 Aug '26◦ | 3 Nov '26◦ |
| Earnings day | −2.95% | +0.05% | −3.47% | +0.46% | −9.16% | +20.00% | −4.96% | +3.97% |
| +1 day | −8.38% | +2.84% | −11.92% | +1.67% | −10.22% | +18.83% | −2.15% | +8.26% |
| +5 days | −8.90% | +6.99% | −11.21% | +1.31% | −17.35% | +10.86% | −7.11% | +13.80% |
| +15 days | +13.30% | +5.65% | −15.63% | −6.09% | −20.40% | +9.17% | −7.68% | — |
| +30 days | +8.90% | +16.63% | −19.46% | −17.46% | −28.69% | +6.88% | −6.51% | — |
| Filing | XBRL | XBRL | XBRL | XBRL |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Sep 202641.75%Promoter
Promoters41.75%0.05
FIIs6.57%23.53
DIIs10.68%0.21
Public41.00%23.79
Ownership trend
Peers
7 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Molbio Diagnosti | ₹1,495.50 | 237.68 | 17,234 | 0.00% | 8 | −86.23% | 259 | −55.36% | 18.48% |
| Poly Medicure | ₹1,635.70 | 52.46 | 16,580 | 0.21% | 95 | −4.31% | 581 | +30.79% | 12.50% |
| Sahajanand Medi | ₹527.60 | 74.68 | 5,363 | 0.00% | 26 | +32.12% | 373 | +24.69% | 11.35% |
| Tarsons Products | ₹303.40 | 197.34 | 1,614 | 0.00% | 0 | −110.24% | 124 | +20.83% | 4.59% |
| Fischer Medical | ₹22.33 | 137.10 | 1,560 | 0.22% | 1 | −94.22% | 107 | +24.50% | 11.45% |
| Laxmi Dental | ₹187.57 | 28.45 | 1,032 | 0.00% | 10 | +17.58% | 80 | +10.03% | 15.05% |
| Q-Line Biotech | ₹396.80 | 16.91 | 926 | 0.00% | 20 | −8.07% | 152 | +5.83% | 22.45% |
| Median: 18 Co. | ₹302.90 | 36.92 | 664 | 0.00% | 5 | −6.19% | 83 | +17.91% | 15.05% |
Filings
Annual reports2
Concall transcripts21
Announcements5
Announcement under Regulation 30 (LODR)-Earnings Call Transcript 7 NovAnnouncement under Regulation 30 (LODR)-Newspaper Publication 5 Nov - Extract of newspaper advertisements published on November 05, 2026, in the Financial Express (English Newspaper) and Mumbai Lakshdeep (Marathi Newspaper), with respect to Unaudited Standalone …Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 - Receipt Of EU Quality Management System Certificate Under Regulation (EU) 2017/745 On Medical Devices And ISO 13485:2016 Certificate By Kids-E-Dental LLP, A Jointly Controlled Entity Of The Company 4 Nov - Kids-e-Dental LLP received EU MDR and ISO 13485 certificates on November 4, 2026.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 4 Nov - Audio recording of Q2FY27 and H1FY27 earnings conference call uploaded on company website.Announcement under Regulation 30 (LODR)-Press Release / Media Release 3 Nov - Laxmi Dental reported Q2 FY27 revenue of ₹79.5 crore and PAT of ₹10.0 crore; H1 revenue ₹154.2 crore.
